Another cracking post Red Bar,
TK mentioned to us that he had Australian nurses fly out to see US clinical practise, Australia is no third world country and I believe our clinical evidence is as good as anyones in the world.
ResApp have also had their pre submission meeting with the FDA almost a year ago which outlined clinical procedure, ResApp have had ample time to fine tune their algorithm and make sure its working to its full capacity.
We may see a discrepancy of 5-10% between Aus and US results which will still make the FDA process a mere formality. Nothing is for certain and the market is definitely pricing RAP cautiously which leaves solid room for a rerate post results.
- Forums
- ASX - By Stock
- RAP
- RAP - The Main Game
RAP - The Main Game, page-1144
-
- There are more pages in this discussion • 461 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some